Theravance Biopharma
TBPH
TBPH
131 hedge funds and large institutions have $401M invested in Theravance Biopharma in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 47 reducing their positions, and 18 closing their positions.
Holders
131
Holders Change
+3
Holders Change %
+2.34%
% of All Funds
1.78%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
36
Reduced
47
Closed
18
Calls
$6K
Puts
$16K
Net Calls
-$10K
Net Calls Change
-$18K
Top Buyers
1 |
NL
1
Nuveen LLC
Charlotte,
North Carolina
|
$3.35M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$3.73M |
3 |
3
Arrowstreet Capital
Boston,
Massachusetts
|
$1.98M |
4 |
4
Acadian Asset Management
Boston,
Massachusetts
|
$1.55M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$3.92M |